AMTX vs IONR

AMTX exhibits weak financial health with a Piotroski F-Score of 4/9, indicating a fragile operational foundation. The absence of an Altman Z-Score and negative profitability metrics—especially a -38.96% profit margin and -8.96% ROA—signal severe operational distress. Despite a 14.2% YoY revenue growth and recent positive EPS surprises, the company remains unprofitable with negative cash flow and extreme liquidity issues (current ratio of 0.07). The stock trades at a price/sales of 0.77, but this is misleading given the lack of sustainable earnings and deteriorating balance sheet. The 52-week price range of $1.22–$3.66 reflects high volatility and speculative risk.

IONR presents a profile of a pre-revenue development company with a Piotroski F-Score of 4/9, indicating stable but mediocre financial health. While the balance sheet is exceptionally clean with zero debt and a high current ratio (8.59), the company is suffering from extreme operational losses with an operating margin of -655.13%. The valuation is distorted by a Price/Sales ratio of 452.34, reflecting a near-total lack of revenue. Technical trends are completely bearish (0/100), and long-term price performance is deeply negative, suggesting the market is discounting the company's ability to reach production.